ArticleInternational journal of cardiology. Heart & vasculature2025
Sex differences in the prevalence and survival of pulmonary hypertension in obstructive hypertrophic cardiomyopathy following septal myectomy.
Article in International journal of cardiology. Heart & vasculature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Highlights recently published in the International Journal of Cardiology Heart & Vasculature on sex differences in susceptibility, manifestation and outcome of cardiovascular diseases.International journal of cardiology. Heart & vasculature · 2026Article
- The role of sex in multiarterial coronary artery bypass grafting: A landmark and risk factor analysis.JTCVS open · 2026Article
- Loss of Type 2 Bone Morphogenetic Protein Receptor Activates NOD-Like Receptor Family Protein 3/Gasdermin E-Mediated Pyroptosis in Pulmonary Arterial Hypertension.Journal of the American Heart Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary hypertension (PH) and female have been linked to a worse survival in patients with obstructive hypertrophic cardiomyopathy (oHCM). However, female patients with PH exhibited a better prognosis than males. Herein, we investigated sex differences in the prevalence and survival of pH in oHCM following septal myectomy. Methods: We consecutively enrolled 1491 patients diagnosed with oHCM. PH was defined as a pulmonary artery systolic pressure (PASP) > 36 mm Hg. Results: Females were older, more likely to experience chest pain and NYHA class III/IV symptoms, and had a higher prevalence of PH (37.6 % vs. 19.9 %, p < 0.001) than males. Multivariable analysis showed that female was an independent risk for PH (OR 2.3, 95 % CI: 1.70-3.11, p < 0.001) though the PASP was comparable between males and females (44.93 ± 10.87 vs. 44.74 ± 9.72 mm Hg, p = 0.856). Over a median follow-up of 36 months [IQR 23.5-52.5 months), 28 deaths and 189 composite endpoints were observed. Kaplan-Meier analysis showed a higher cumulative incidence of death (p = 0.015) and composite endpoints (p < 0.001) in patients with PH, and Cox regression analysis revealed that PH (HR 1.78, 95 % CI: 1.30-2.45, p < 0.001) and female (HR 1.39, 95 % CI: 1.02-1.90, p = 0.038) were independently associated with composite endpoints. However, no significant survival differences were found between males and females within the PH subgroup. Conclusions: Female was independently associated with higher prevalence but not severity of PH. Although PH and female were independently associated with worse survival, no survival difference was found between males and females in the PH subgroup.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.